(PDF) The Use of Circulating Tumor DNA to Monitor and

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer

Frontiers in Genetics - Switzerland

doi 10.3389/fgene.2019.01118

Full Text

Abstract

Available in full text

Categories

Molecular Medicine

Date

November 21, 2019

Authors

Paul Hollington

Christos S. Karapetis

Sina Vatandoust

Graeme P. Young

Erin L. Symonds

Publisher

Frontiers Media SA

Related search

Circulating Tumor DNA to Monitor Treatment Response and Detect Acquired Resistance in Patients With Metastatic Melanoma

English

Assessing Tumor Heterogeneity Using ctDNA to Predict and Monitor Therapeutic Response in Metastatic Breast Cancer

International Journal of Cancer

Cancer Research

English

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer

English

Early Change in Circulating Tumor DNA as a Potential Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer

Scientific Reports

Multidisciplinary

English

Circulating Tumor DNA Detectable in Early- And Late-Stage Colorectal Cancer Patients

Bioscience Reports

Molecular Biology

English

Diffuse Reflectance Spectroscopy to Monitor Murine Colorectal Tumor Progression and Therapeutic Response

Journal of Biomedical Optics

Molecular Physics,

Magnetic Materials

Biomedical Engineering

English

EGFR Inhibitor as Second-Line Therapy in a Patient With Mutant RAS Metastatic Colorectal Cancer: Circulating Tumor DNA to Personalize Treatment

JCO Precision Oncology

Cancer Research

English

Diffuse Reflectance Spectroscopy to Monitor Murine Colorectal Tumor Progression and Therapeutic Response (Erratum)

Journal of Biomedical Optics

Molecular Physics,

Magnetic Materials

Biomedical Engineering

English

Change in Circulating Tumor DNA After Hepatic Resection for Metastatic Colorectal Cancer

Gastroenterology

English